NRF2 functions as a principal regulator of antioxidation and cytoprotection that functions mechanistically by binding to antioxidant response elements (AREs) and has exhibited the potential to treat obesity and type 2 diabetes (27). This evidence concerns the gene NFE2L2 and type 2 diabetes mellitus.